Trial Profile
Telithromycin, treating adult outpatients with mild to moderate community-acquired pneumonia (CAP) in high bacterial resistance areas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2007
Price :
$35
*
At a glance
- Drugs Antibacterials; Telithromycin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Sanofi
- 09 Oct 2007 New trial record.